Skip to main content

and
  1. No Access

    Article

    Aprepitant, fosaprepitant and risk of ifosfamide-induced neurotoxicity: a systematic review

    Ifosfamide is one of the chemotherapy regimens which potentially causes neurotoxicity in patients up to 30%. Aprepitant is administered as an anti-emetic agent in chemotherapy and regarding the inhibitory effe...

    Fatemeh Vazirian, Sara Samadi, Hossein Rahimi in Cancer Chemotherapy and Pharmacology (2022)

  2. Article

    Open Access

    Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial

    In this study, we investigate the effect of hydroxychloroquine on the prevention of Novel Coronavirus Disease (COVID-19) in cancer patients being treated.

    Abolghasem Allahyari, Hossein Rahimi, Majid Khadem-Rezaiyan, Zahra Mozaheb in Trials (2020)

  3. No Access

    Article

    JAK2 V617F Mutation in Adult T Cell Leukemia-Lymphoma

    Adult T cell Leukemia/lymphoma (ATL) is a mature T-cell neoplasm that has strong association with the human T-lymphotropic virus type 1 (HTLV-I) infection. This infection is endemic in our region (north easter...

    Hossein Ayatollahi, Mohammad Hadi Sadeghian in Indian Journal of Hematology and Blood Tra… (2016)

  4. No Access

    Article

    Modified Irinotecan Plus Cisplatin and Dexamethasone (ICD) Combination Chemotherapy as Salvage Chemotherapy for Patients with Relapsed/Refractory Diffuse Large Cell Lymphoma

    About 50 % of patients with diffuse large cell lymphoma are candidate for salvage chemotherapy followed by bone marrow transplantation in the selected patients. In the current study we evaluated modified ICD (...

    Mojtaba Ghadiany, Mohammad Foratyazdi in Indian Journal of Hematology and Blood Tra… (2014)